
    
      The aim of the study is to determine the diagnostic utility of the device 'Electronic Nose'
      for Pleural TB, which is a Extra pulmonary TB form.

      The patient who qualified for the study, according to the inclusion criteria, after
      consenting, will be guided through and oriented survey for risk factors, then a complete
      physical exam, and after that, the patient will breathe for 5 minutes trough the device,
      which stores the patient information, that later will be download to a computer and will be
      send to the server's manufacturer company, in Netherlands.

      During and after the use of the device, investigators determine the adverse effects of the
      intervention, according to the CTCEA.

      Investigators use the pleural biopsy, which is the gold standard, to determine the diagnostic
      utility of the test. And, will compare the results with other tests currently perform as the
      regular diagnostic routine, such as Chest CT, adenosine deaminase value of pleural fluid and
      cytomorphologic & cytochemistry of the pleural fluid.

      Patient Registries will be keep in an electronic database, as well as handwriting history,
      with the backup copy in the records of the hospital in which the patient was admitted.

      Auditories will be realised by the Ethics Committee in different time frames.
    
  